Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Genprex Inc (NQ: GNPX )

3.550 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 69
Open 3.550
Bid (Size) 3.400 (10)
Ask (Size) 3.550 (4)
Prev. Close 3.550
Today's Range 3.550 - 3.550
52wk Range 2.810 - 7.720
Shares Outstanding 47,363,729
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer Following FDA Review
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced... 
From Business Wire News Releases
Diamond Equity Research Emerging Growth Invitational Spring 2021 Virtual Conference
From ACCESSWIRE

Performance

YTD
-14.04%
-14.04%
1 Month
-1.11%
-1.11%
3 Month
-20.76%
-20.76%
6 Month
-24.31%
-24.31%
1 Year
-2.47%
-2.47%

More News

Read More
Genprex Announces Participation in Noble Capital Markets’ Virtual Roadshow Series
From Business Wire News Releases
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present in Noble Capital Markets’ Virtual Roadshow
From InvestorBrandNetwork
Genprex to Participate in Upcoming May Investor Conferences
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation Schedule for May Investor Conferences
From InvestorBrandNetwork
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Expansion of World-Class IP Portfolio
From InvestorBrandNetwork
Genprex In-Licenses Additional Gene Therapy Technologies for Treatment of Lung Cancer
From Business Wire News Releases
12 Health Care Stocks Moving In Wednesday's Intraday Session
Tags Intraday Update ADMP MLND
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tags MTP Pre/Market Outlook NMRD
From Benzinga
OMFS's Underlying Holdings Could Mean 12% Gain Potential
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]